The clinical use of fibrin sealant in cardiovascular surgery

Chen An-qing,Wang Zhe,Wang Chun-sheng,Zhao Qiang,Xu De-min
DOI: https://doi.org/10.3969/j.issn.1006-0111.2005.06.010
2005-01-01
Abstract:Objective: To assess the hemostatic effect and security of fibrin sealant in cardiovascular surgery. Methods: 60 patients who were performed open-heart operations with incisions on aorta or right ventricle were divided randomly into test group or control group. Each group contains 30 patients. FS(test group) or NS(control group) were local used on the incisions in these patients. The hemostatic time and bleeding quantity were used as main evaluating indicators. 7 patients of test group underwent 3 months followup for the security. Results:The hemostatic time(14.67±6.18s) and bleeding quantity(0.81±0.54g) of test group were obviously better than control group(250.45±37.02s and 15.39±2.69g). Conclusion: Fibrin sealant has good effects of hemostasis and tissue conglutination in cardiovascular surgery.
What problem does this paper attempt to address?